Success Metrics

Clinical Success Rate
87.1%

Based on 61 completed trials

Completion Rate
87%(61/70)
Active Trials
25(18%)
Results Posted
21%(13 trials)
Terminated
9(7%)

Phase Distribution

Ph phase_2
28
20%
Ph phase_3
5
4%
Ph phase_1
24
18%
Ph early_phase_1
9
7%
Ph phase_4
22
16%
Ph not_applicable
38
28%

Phase Distribution

33

Early Stage

28

Mid Stage

27

Late Stage

Phase Distribution126 total trials
Early Phase 1First-in-human
9(7.1%)
Phase 1Safety & dosage
24(19.0%)
Phase 2Efficacy & side effects
28(22.2%)
Phase 3Large-scale testing
5(4.0%)
Phase 4Post-market surveillance
22(17.5%)
N/ANon-phased studies
38(30.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.3%

61 of 76 finished

Non-Completion Rate

19.7%

15 ended early

Currently Active

25

trials recruiting

Total Trials

137

all time

Status Distribution
Active(36)
Completed(61)
Terminated(15)
Other(25)

Detailed Status

Completed61
unknown25
Recruiting22
Not yet recruiting11
Terminated9
Withdrawn6

Development Timeline

Analytics

Development Status

Total Trials
137
Active
25
Success Rate
87.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 19 (7.1%)
Phase 124 (19.0%)
Phase 228 (22.2%)
Phase 35 (4.0%)
Phase 422 (17.5%)
N/A38 (30.2%)

Trials by Status

not_yet_recruiting118%
recruiting2216%
completed6145%
terminated97%
unknown2518%
withdrawn64%
active_not_recruiting32%

Recent Activity

Clinical Trials (137)

Showing 20 of 137 trialsScroll for more
NCT04340752Phase 1

Optimal Dosing of IC-Green for Visualization of Rotator Cuff Vascularity Using Advanced Imaging Modality Arthroscopy

Completed
NCT07146295Not Applicable

Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer

Recruiting
NCT07650656Phase 2

Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial

Recruiting
NCT07635420Phase 4

Comparing Intraoperative Indocyanine Green Fluorescence Imaging With Standard Clinical Assessment for Flap Perfusion in Head and Neck Reconstruction (VISION Trial)

Not Yet Recruiting
NCT05197530Phase 1

Imaging of Lymphatic Vessels in People With Rheumatoid Arthritis (RA)

Recruiting
NCT03941756Not Applicable

Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma

Recruiting
NCT07593339Not Applicable

Sentinel Lymph Node Mapping in Early-Stage Epithelial Ovarian Cancer Surgery

Not Yet Recruiting
NCT06169735Phase 4

Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation

Terminated
NCT05645523Early Phase 1

Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors

Recruiting
NCT04084067Phase 1

Indocyanine Green (ICG) Guided Tumor Resection

Recruiting
NCT04752137Phase 2

Intraoperative Tumor Margin Identification With ICG Dye Imaging

Recruiting
NCT07502053Not Applicable

Evaluation of the Perfusion of the Pancreatic Remnant With Indocyanine Green and Its Impact on the Reduction of Pancreatic Fistula After Pancreaticoduodenectomy

Recruiting
NCT04723810Phase 1

TumorGlow Intraoperative Molecular Imaging (IMI)

Recruiting
NCT05038098Phase 1

Magnetic Sentinel Lymph Node Mapping in Gastric Cancer

Not Yet Recruiting
NCT07250854Early Phase 1

The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis

Recruiting
NCT06327490Phase 2

A Study Evaluating the Feasibility and Compliance of Manual Lymphatic Drainage Comparing Indocyanine-Green (ICG) Guided vs. Traditional Guided in Patients Undergoing Axillary Node Dissection for the Treatment of Breast Cancer

Recruiting
NCT02967848

Liver Function Investigation With SPECT

Active Not Recruiting
NCT02570815Phase 1

Near-Infrared Fluorescence Guided Robotic Pulmonary Segmentectomy for Early Stage Lung Cancer

Recruiting
NCT03262636Phase 1

Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow)

Completed
NCT07315828Phase 4

Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone Surgery

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
137